-X	-	-	Acute erythroleukemia (FAB type M6)
-X	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-X	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-X	-	-	Acute monoblastic leukemia (FAB type M5)
-X	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-X	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-X	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-X	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-X	-	-	Acute myeloid leukemia, NOS
-X	-	-	Acute myelomonocytic leukemia (FAB type M4)
-X	-	-	Acute promyelocytic leukemia (FAB type M3)
-X	-	-	Acute undifferentiated leukemia
-X	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-X	-	-	Aggressive NK-cell leukemia
-X	-	-	Anaplastic large cell lymphoma, systemic type
-X	-	-	Angioimmunoblastic T-cell lymphoma
-X	-	-	Bilineage or biphenotypic leukemia
-X	-	-	B-prolymphocytic leukemia
-X	-	-	Burkitt lymphoma/leukemia
-X	-	-	Chronic lymphocytic leukemia
-X	-	-	Chronic myeloid leukemia, aberrant translocation
-X	-	-	Chronic myeloid leukemia, t(9;22)
-X	-	-	Chronic myelomonocytic leukemia
-X	-	-	Diffuse large B-cell lymphoma
-X	-	-	Essential thrombocythemia
-X	-	-	Extranodal NK/T-cell lymphoma
-X	-	-	Follicular lymphoma
-X	-	-	Hairy cell leukemia
-X	-	-	Hepatosplenic T-cell lymphoma
-X	-	-	Hodgkin disease, lymphocyte depletion
-X	-	-	Hodgkin disease, lymphocyte predominance
-X	-	-	Hodgkin disease, mixed cellularity
-X	-	-	Hodgkin disease, nodular sclerosis
-X	-	-	Hodgkin disease, NOS
-X	-	-	Mantle cell lymphoma
-X	-	-	Mature B-cell neoplasm, NOS
-X	-	-	Mature T- and NK-cell neoplasm, NOS
-X	-	-	Multiple myeloma
-X	-	-	Mycosis fungoides/S&eacute;zary syndrome
-X	-	-	Myelodysplastic/myeloproliferative disease, NOS
-X	-	-	Myelodysplastic syndrome, NOS
-X	-	-	Nodal marginal zone B-cell lymphoma
-X	-	-	Nonneoplastic hematologic disorder/lesion
-X	-	-	Peripheral T-cell lymphoma, unspecified
-X	-	-	Plasma cell leukemia
-X	-	-	Polycythemia vera
-X	-	-	Primary effusion lymphoma
-X	-	-	Refractory anemia
-X	-	-	Refractory anemia with excess blasts-2
-X	-	-	Refractory anemia with excess of blasts (FAB)
-X	-	-	Refractory anemia with ringed sideroblasts
-X	-	-	Refractory cytopenia with multilineage dysplasia
-X	-	-	Splenic marginal zone B-cell lymphoma
-X	-	-	T-prolymphocytic leukemia
-X	-	-	Waldenstr&ouml;m macroglobulinemia
-Y	-	-	Acute erythroleukemia (FAB type M6)
-Y	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-Y	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-Y	-	-	Acute monoblastic leukemia (FAB type M5)
-Y	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-Y	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-Y	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-Y	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-Y	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-Y	-	-	Acute myeloid leukemia, NOS
-Y	-	-	Acute myeloid leukemia, special type
-Y	-	-	Acute myelomonocytic leukemia (FAB type M4)
-Y	-	-	Acute promyelocytic leukemia (FAB type M3)
-Y	-	-	Acute undifferentiated leukemia
-Y	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-Y	-	-	Aggressive NK-cell leukemia
-Y	-	-	Anaplastic large cell lymphoma, cutaneous type
-Y	-	-	Anaplastic large cell lymphoma, systemic type
-Y	-	-	Angioimmunoblastic T-cell lymphoma
-Y	-	-	Atypical chronic myeloid leukemia
-Y	-	-	Bilineage or biphenotypic leukemia
-Y	-	-	B-prolymphocytic leukemia
-Y	-	-	Burkitt lymphoma/leukemia
-Y	-	-	Chronic eosinophilic leukemia/hypereosinophilic syndrome
-Y	-	-	Chronic lymphocytic leukemia
-Y	-	-	Chronic myeloid leukemia, aberrant translocation
-Y	-	-	Chronic myeloid leukemia, t(9;22)
-Y	-	-	Chronic myelomonocytic leukemia
-Y	-	-	Chronic myeloproliferative disorder, NOS
-Y	-	-	Dendritic cell neoplasm
-Y	-	-	Diffuse large B-cell lymphoma
-Y	-	-	Essential thrombocythemia
-Y	-	-	Extranodal NK/T-cell lymphoma
-Y	-	-	Follicular lymphoma
-Y	-	-	Hairy cell leukemia
-Y	-	-	Hepatosplenic T-cell lymphoma
-Y	-	-	Hodgkin disease, lymphocyte depletion
-Y	-	-	Hodgkin disease, lymphocyte predominance
-Y	-	-	Hodgkin disease, mixed cellularity
-Y	-	-	Hodgkin disease, nodular sclerosis
-Y	-	-	Hodgkin disease, NOS
-Y	-	-	Idiopathic myelofibrosis
-Y	-	-	Intravascular large B-cell lymphoma
-Y	-	-	Juvenile myelomonocytic leukemia
-Y	-	-	Lymphoplasmacytic lymphoma
-Y	-	-	Mantle cell lymphoma
-Y	-	-	Mastocytosis
-Y	-	-	Mature B-cell neoplasm, NOS
-Y	-	-	Mature B-cell neoplasm, special type
-Y	-	-	Mature T- and NK-cell neoplasm, NOS
-Y	-	-	Mediastinal large B-cell lymphoma
-Y	-	-	Monoclonal gammopathy of undetermined significance
-Y	-	-	Multiple myeloma
-Y	-	-	Mycosis fungoides/S&eacute;zary syndrome
-Y	-	-	Myelodysplastic syndrome, NOS
-Y	-	-	Nodal marginal zone B-cell lymphoma
-Y	-	-	Nonneoplastic hematologic disorder/lesion
-Y	-	-	Peripheral T-cell lymphoma, unspecified
-Y	-	-	Plasma cell leukemia
-Y	-	-	Plasma cell neoplasm, NOS
-Y	-	-	Polycythemia vera
-Y	-	-	Post-transplant lymphoproliferative disorder
-Y	-	-	Primary effusion lymphoma
-Y	-	-	Refractory anemia
-Y	-	-	Refractory anemia with excess blasts-1
-Y	-	-	Refractory anemia with excess blasts-2
-Y	-	-	Refractory anemia with excess of blasts (FAB)
-Y	-	-	Refractory anemia with ringed sideroblasts
-Y	-	-	Refractory cytopenia with multilineage dysplasia
-Y	-	-	Splenic marginal zone B-cell lymphoma
-Y	-	-	T-cell granular lymphocytic leukemia
-Y	-	-	T-prolymphocytic leukemia
-Y	-	-	Waldenstr&ouml;m macroglobulinemia
-1	-	-	Acute erythroleukemia (FAB type M6)
-1	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-1	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-1	-	-	Acute monoblastic leukemia (FAB type M5)
-1	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-1	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-1	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-1	-	-	Acute myeloid leukemia, NOS
-1	-	-	Acute myelomonocytic leukemia (FAB type M4)
-1	-	-	Acute promyelocytic leukemia (FAB type M3)
-1	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-1	-	-	Bilineage or biphenotypic leukemia
-1	-	-	Burkitt lymphoma/leukemia
-1	-	-	Chronic lymphocytic leukemia
-1	-	-	Chronic myeloid leukemia, aberrant translocation
-1	-	-	Chronic myeloid leukemia, t(9;22)
-1	-	-	Chronic myelomonocytic leukemia
-1	-	-	Dendritic cell neoplasm
-1	-	-	Diffuse large B-cell lymphoma
-1	-	-	Follicular lymphoma
-1	-	-	Hodgkin disease, lymphocyte predominance
-1	-	-	Hodgkin disease, mixed cellularity
-1	-	-	Hodgkin disease, nodular sclerosis
-1	-	-	Hodgkin disease, NOS
-1	-	-	Intravascular large B-cell lymphoma
-1	-	-	Mantle cell lymphoma
-1	-	-	Mature B-cell neoplasm, NOS
-1	-	-	Mature T- and NK-cell neoplasm, NOS
-1	-	-	Mediastinal large B-cell lymphoma
-1	-	-	Multiple myeloma
-1	-	-	Mycosis fungoides/S&eacute;zary syndrome
-1	-	-	Myelodysplastic syndrome, NOS
-1	-	-	Nodal marginal zone B-cell lymphoma
-1	-	-	Peripheral T-cell lymphoma, unspecified
-1	-	-	Plasma cell leukemia
-1	-	-	Refractory anemia
-1	-	-	Refractory anemia with excess of blasts (FAB)
-1	-	-	Splenic marginal zone B-cell lymphoma
-1	-	-	T-prolymphocytic leukemia
-2	-	-	Acute erythroleukemia (FAB type M6)
-2	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-2	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-2	-	-	Acute monoblastic leukemia (FAB type M5)
-2	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-2	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-2	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-2	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-2	-	-	Acute myeloid leukemia, NOS
-2	-	-	Acute myeloid leukemia, special type
-2	-	-	Acute myelomonocytic leukemia (FAB type M4)
-2	-	-	Acute promyelocytic leukemia (FAB type M3)
-2	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-2	-	-	Anaplastic large cell lymphoma, systemic type
-2	-	-	Bilineage or biphenotypic leukemia
-2	-	-	B-prolymphocytic leukemia
-2	-	-	Burkitt lymphoma/leukemia
-2	-	-	Chronic lymphocytic leukemia
-2	-	-	Chronic myeloid leukemia, t(9;22)
-2	-	-	Diffuse large B-cell lymphoma
-2	-	-	Extranodal NK/T-cell lymphoma
-2	-	-	Follicular lymphoma
-2	-	-	Hairy cell leukemia
-2	-	-	Hodgkin disease, lymphocyte predominance
-2	-	-	Hodgkin disease, mixed cellularity
-2	-	-	Hodgkin disease, nodular sclerosis
-2	-	-	Mantle cell lymphoma
-2	-	-	Mastocytosis
-2	-	-	Mature B-cell neoplasm, NOS
-2	-	-	Mature T- and NK-cell neoplasm, NOS
-2	-	-	Multiple myeloma
-2	-	-	Mycosis fungoides/S&eacute;zary syndrome
-2	-	-	Myelodysplastic syndrome, NOS
-2	-	-	Nodal marginal zone B-cell lymphoma
-2	-	-	Peripheral T-cell lymphoma, unspecified
-2	-	-	Plasma cell leukemia
-2	-	-	Primary effusion lymphoma
-2	-	-	Refractory anemia
-2	-	-	Refractory anemia with excess blasts-2
-2	-	-	Refractory anemia with excess of blasts (FAB)
-2	-	-	Splenic marginal zone B-cell lymphoma
-2	-	-	T-prolymphocytic leukemia
-2	-	-	Waldenstr&ouml;m macroglobulinemia
-3	-	-	Acute erythroleukemia (FAB type M6)
-3	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-3	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-3	-	-	Acute monoblastic leukemia (FAB type M5)
-3	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-3	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-3	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-3	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-3	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-3	-	-	Acute myeloid leukemia, NOS
-3	-	-	Acute myelomonocytic leukemia (FAB type M4)
-3	-	-	Acute promyelocytic leukemia (FAB type M3)
-3	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-3	-	-	Aggressive NK-cell leukemia
-3	-	-	Angioimmunoblastic T-cell lymphoma
-3	-	-	Bilineage or biphenotypic leukemia
-3	-	-	B-prolymphocytic leukemia
-3	-	-	Burkitt lymphoma/leukemia
-3	-	-	Chronic lymphocytic leukemia
-3	-	-	Chronic myeloid leukemia, aberrant translocation
-3	-	-	Chronic myeloid leukemia, t(9;22)
-3	-	-	Chronic myelomonocytic leukemia
-3	-	-	Diffuse large B-cell lymphoma
-3	-	-	Essential thrombocythemia
-3	-	-	Follicular lymphoma
-3	-	-	Hairy cell leukemia
-3	-	-	Hodgkin disease, lymphocyte depletion
-3	-	-	Hodgkin disease, lymphocyte predominance
-3	-	-	Hodgkin disease, mixed cellularity
-3	-	-	Hodgkin disease, nodular sclerosis
-3	-	-	Hodgkin disease, NOS
-3	-	-	Idiopathic myelofibrosis
-3	-	-	Mantle cell lymphoma
-3	-	-	Mastocytosis
-3	-	-	Mature B-cell neoplasm, NOS
-3	-	-	Mature T- and NK-cell neoplasm, NOS
-3	-	-	Multiple myeloma
-3	-	-	Mycosis fungoides/S&eacute;zary syndrome
-3	-	-	Myelodysplastic syndrome, NOS
-3	-	-	Peripheral T-cell lymphoma, unspecified
-3	-	-	Plasma cell leukemia
-3	-	-	Polycythemia vera
-3	-	-	Refractory anemia
-3	-	-	Refractory anemia with excess blasts-1
-3	-	-	Refractory anemia with excess blasts-2
-3	-	-	Refractory anemia with excess of blasts (FAB)
-3	-	-	Refractory anemia with ringed sideroblasts
-3	-	-	Refractory cytopenia with multilineage dysplasia
-3	-	-	T-cell granular lymphocytic leukemia
-3	-	-	T-prolymphocytic leukemia
-4	-	-	Acute erythroleukemia (FAB type M6)
-4	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-4	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-4	-	-	Acute monoblastic leukemia (FAB type M5)
-4	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-4	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-4	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-4	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-4	-	-	Acute myeloid leukemia, NOS
-4	-	-	Acute myeloid leukemia, special type
-4	-	-	Acute myelomonocytic leukemia (FAB type M4)
-4	-	-	Acute promyelocytic leukemia (FAB type M3)
-4	-	-	Acute undifferentiated leukemia
-4	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-4	-	-	Anaplastic large cell lymphoma, systemic type
-4	-	-	Angioimmunoblastic T-cell lymphoma
-4	-	-	Bilineage or biphenotypic leukemia
-4	-	-	Burkitt lymphoma/leukemia
-4	-	-	Chronic lymphocytic leukemia
-4	-	-	Chronic myeloid leukemia, aberrant translocation
-4	-	-	Chronic myeloid leukemia, t(9;22)
-4	-	-	Chronic myelomonocytic leukemia
-4	-	-	Chronic myeloproliferative disorder, NOS
-4	-	-	Diffuse large B-cell lymphoma
-4	-	-	Follicular lymphoma
-4	-	-	Hodgkin disease, lymphocyte depletion
-4	-	-	Hodgkin disease, lymphocyte predominance
-4	-	-	Hodgkin disease, mixed cellularity
-4	-	-	Hodgkin disease, nodular sclerosis
-4	-	-	Hodgkin disease, NOS
-4	-	-	Intravascular large B-cell lymphoma
-4	-	-	Mantle cell lymphoma
-4	-	-	Mastocytosis
-4	-	-	Mature B-cell neoplasm, NOS
-4	-	-	Mature T- and NK-cell neoplasm, NOS
-4	-	-	Multiple myeloma
-4	-	-	Mycosis fungoides/S&eacute;zary syndrome
-4	-	-	Myelodysplastic syndrome, NOS
-4	-	-	Peripheral T-cell lymphoma, unspecified
-4	-	-	Plasma cell leukemia
-4	-	-	Polycythemia vera
-4	-	-	Refractory anemia
-4	-	-	Refractory anemia with excess blasts-1
-4	-	-	Refractory anemia with excess blasts-2
-4	-	-	Refractory anemia with excess of blasts (FAB)
-4	-	-	Refractory anemia with ringed sideroblasts
-4	-	-	Splenic marginal zone B-cell lymphoma
-4	-	-	T-prolymphocytic leukemia
-4	-	-	Waldenstr&ouml;m macroglobulinemia
-5	-	-	Acute erythroleukemia (FAB type M6)
-5	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-5	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-5	-	-	Acute monoblastic leukemia (FAB type M5)
-5	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-5	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-5	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-5	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-5	-	-	Acute myeloid leukemia, NOS
-5	-	-	Acute myelomonocytic leukemia (FAB type M4)
-5	-	-	Acute promyelocytic leukemia (FAB type M3)
-5	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-5	-	-	Aggressive NK-cell leukemia
-5	-	-	Angioimmunoblastic T-cell lymphoma
-5	-	-	Bilineage or biphenotypic leukemia
-5	-	-	Burkitt lymphoma/leukemia
-5	-	-	Chronic lymphocytic leukemia
-5	-	-	Chronic myeloid leukemia, aberrant translocation
-5	-	-	Chronic myeloid leukemia, t(9;22)
-5	-	-	Chronic myelomonocytic leukemia
-5	-	-	Chronic myeloproliferative disorder, NOS
-5	-	-	Dendritic cell neoplasm
-5	-	-	Diffuse large B-cell lymphoma
-5	-	-	Essential thrombocythemia
-5	-	-	Follicular lymphoma
-5	-	-	Hodgkin disease, lymphocyte predominance
-5	-	-	Hodgkin disease, mixed cellularity
-5	-	-	Hodgkin disease, nodular sclerosis
-5	-	-	Idiopathic myelofibrosis
-5	-	-	Mantle cell lymphoma
-5	-	-	Mature B-cell neoplasm, NOS
-5	-	-	Mature T- and NK-cell neoplasm, NOS
-5	-	-	Multiple myeloma
-5	-	-	Mycosis fungoides/S&eacute;zary syndrome
-5	-	-	Myelodysplastic syndrome, NOS
-5	-	-	Nonneoplastic hematologic disorder/lesion
-5	-	-	Peripheral T-cell lymphoma, unspecified
-5	-	-	Plasma cell leukemia
-5	-	-	Polycythemia vera
-5	-	-	Primary effusion lymphoma
-5	-	-	Refractory anemia
-5	-	-	Refractory anemia with excess blasts-1
-5	-	-	Refractory anemia with excess blasts-2
-5	-	-	Refractory anemia with excess of blasts (FAB)
-5	-	-	Refractory anemia with ringed sideroblasts
-5	-	-	Refractory cytopenia with multilineage dysplasia
-5	-	-	Splenic marginal zone B-cell lymphoma
-5	-	-	T-prolymphocytic leukemia
-6	-	-	Acute erythroleukemia (FAB type M6)
-6	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-6	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-6	-	-	Acute monoblastic leukemia (FAB type M5)
-6	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-6	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-6	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-6	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-6	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-6	-	-	Acute myeloid leukemia, NOS
-6	-	-	Acute myelomonocytic leukemia (FAB type M4)
-6	-	-	Acute promyelocytic leukemia (FAB type M3)
-6	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-6	-	-	Anaplastic large cell lymphoma, systemic type
-6	-	-	Angioimmunoblastic T-cell lymphoma
-6	-	-	Astrocytoma, grade I-II
-6	-	-	Bilineage or biphenotypic leukemia
-6	-	-	B-prolymphocytic leukemia
-6	-	-	Burkitt lymphoma/leukemia
-6	-	-	Chronic lymphocytic leukemia
-6	-	-	Chronic myeloid leukemia, t(9;22)
-6	-	-	Chronic myelomonocytic leukemia
-6	-	-	Chronic myeloproliferative disorder, NOS
-6	-	-	Dendritic cell neoplasm
-6	-	-	Diffuse large B-cell lymphoma
-6	-	-	Follicular lymphoma
-6	-	-	Hairy cell leukemia
-6	-	-	Hodgkin disease, lymphocyte depletion
-6	-	-	Hodgkin disease, mixed cellularity
-6	-	-	Hodgkin disease, nodular sclerosis
-6	-	-	Hodgkin disease, NOS
-6	-	-	Idiopathic myelofibrosis
-6	-	-	Intravascular large B-cell lymphoma
-6	-	-	Juvenile myelomonocytic leukemia
-6	-	-	Lymphoplasmacytic lymphoma
-6	-	-	Mantle cell lymphoma
-6	-	-	Mature B-cell neoplasm, NOS
-6	-	-	Mature T- and NK-cell neoplasm, NOS
-6	-	-	Multiple myeloma
-6	-	-	Mycosis fungoides/S&eacute;zary syndrome
-6	-	-	Myelodysplastic syndrome, NOS
-6	-	-	Nodal marginal zone B-cell lymphoma
-6	-	-	Peripheral T-cell lymphoma, unspecified
-6	-	-	Plasma cell leukemia
-6	-	-	Refractory anemia
-6	-	-	Refractory anemia with excess blasts-1
-6	-	-	Refractory anemia with excess blasts-2
-6	-	-	Refractory anemia with excess of blasts (FAB)
-6	-	-	Refractory cytopenia with multilineage dysplasia
-6	-	-	Splenic marginal zone B-cell lymphoma
-6	-	-	T-prolymphocytic leukemia
-6	-	-	Waldenstr&ouml;m macroglobulinemia
-7	-	-	Acute basophilic leukemia
-7	-	-	Acute eosinophilic leukemia
-7	-	-	Acute erythroleukemia (FAB type M6)
-7	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-7	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-7	-	-	Acute monoblastic leukemia (FAB type M5)
-7	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-7	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-7	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-7	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-7	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-7	-	-	Acute myeloid leukemia, NOS
-7	-	-	Acute myelomonocytic leukemia (FAB type M4)
-7	-	-	Acute promyelocytic leukemia (FAB type M3)
-7	-	-	Acute undifferentiated leukemia
-7	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-7	-	-	Aggressive NK-cell leukemia
-7	-	-	Atypical chronic myeloid leukemia
-7	-	-	B-cell lymphoma associated with hemophagocytic syndrome
-7	-	-	Bilineage or biphenotypic leukemia
-7	-	-	B-prolymphocytic leukemia
-7	-	-	Burkitt lymphoma/leukemia
-7	-	-	Chronic eosinophilic leukemia/hypereosinophilic syndrome
-7	-	-	Chronic lymphocytic leukemia
-7	-	-	Chronic myeloid leukemia, aberrant translocation
-7	-	-	Chronic myeloid leukemia, t(9;22)
-7	-	-	Chronic myelomonocytic leukemia
-7	-	-	Chronic myeloproliferative disorder, NOS
-7	-	-	Diffuse large B-cell lymphoma
-7	-	-	Essential thrombocythemia
-7	-	-	Follicular lymphoma
-7	-	-	Hairy cell leukemia
-7	-	-	Hodgkin disease, lymphocyte depletion
-7	-	-	Hodgkin disease, lymphocyte predominance
-7	-	-	Hodgkin disease, mixed cellularity
-7	-	-	Hodgkin disease, nodular sclerosis
-7	-	-	Hodgkin disease, NOS
-7	-	-	Idiopathic myelofibrosis
-7	-	-	Juvenile myelomonocytic leukemia
-7	-	-	Mantle cell lymphoma
-7	-	-	Mastocytosis
-7	-	-	Mature B-cell neoplasm, NOS
-7	-	-	Mature T- and NK-cell neoplasm, NOS
-7	-	-	Multiple myeloma
-7	-	-	Mycosis fungoides/S&eacute;zary syndrome
-7	-	-	Myelodysplastic/myeloproliferative disease, NOS
-7	-	-	Myelodysplastic syndrome, NOS
-7	-	-	Nodal marginal zone B-cell lymphoma
-7	-	-	Nonneoplastic hematologic disorder/lesion
-7	-	-	Peripheral T-cell lymphoma, unspecified
-7	-	-	Plasma cell leukemia
-7	-	-	Polycythemia vera
-7	-	-	Primary amyloidosis
-7	-	-	Refractory anemia
-7	-	-	Refractory anemia with excess blasts-1
-7	-	-	Refractory anemia with excess blasts-2
-7	-	-	Refractory anemia with excess of blasts (FAB)
-7	-	-	Refractory anemia with ringed sideroblasts
-7	-	-	Refractory cytopenia with multilineage dysplasia
-7	-	-	Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
-7	-	-	Splenic marginal zone B-cell lymphoma
-7	-	-	T-cell granular lymphocytic leukemia
-7	-	-	T-prolymphocytic leukemia
-7	-	-	Waldenstr&ouml;m macroglobulinemia
-8	-	-	Acute erythroleukemia (FAB type M6)
-8	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-8	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-8	-	-	Acute monoblastic leukemia (FAB type M5)
-8	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-8	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-8	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-8	-	-	Acute myeloid leukemia, NOS
-8	-	-	Acute myeloid leukemia, special type
-8	-	-	Acute myelomonocytic leukemia (FAB type M4)
-8	-	-	Acute promyelocytic leukemia (FAB type M3)
-8	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-8	-	-	Anaplastic large cell lymphoma, systemic type
-8	-	-	Angioimmunoblastic T-cell lymphoma
-8	-	-	B-cell lymphoma associated with hemophagocytic syndrome
-8	-	-	Bilineage or biphenotypic leukemia
-8	-	-	B-prolymphocytic leukemia
-8	-	-	Burkitt lymphoma/leukemia
-8	-	-	Chronic lymphocytic leukemia
-8	-	-	Chronic myeloid leukemia, t(9;22)
-8	-	-	Chronic myelomonocytic leukemia
-8	-	-	Chronic myeloproliferative disorder, NOS
-8	-	-	Diffuse large B-cell lymphoma
-8	-	-	Follicular lymphoma
-8	-	-	Hairy cell leukemia
-8	-	-	Hodgkin disease, lymphocyte depletion
-8	-	-	Hodgkin disease, mixed cellularity
-8	-	-	Hodgkin disease, nodular sclerosis
-8	-	-	Hodgkin disease, NOS
-8	-	-	Idiopathic myelofibrosis
-8	-	-	Intravascular large B-cell lymphoma
-8	-	-	Juvenile myelomonocytic leukemia
-8	-	-	Lymphoplasmacytic lymphoma
-8	-	-	Mantle cell lymphoma
-8	-	-	Mature B-cell neoplasm, NOS
-8	-	-	Mature T- and NK-cell neoplasm, NOS
-8	-	-	Monoclonal gammopathy of undetermined significance
-8	-	-	Multiple myeloma
-8	-	-	Mycosis fungoides/S&eacute;zary syndrome
-8	-	-	Myelodysplastic syndrome, NOS
-8	-	-	Peripheral T-cell lymphoma, unspecified
-8	-	-	Plasma cell leukemia
-8	-	-	Refractory anemia
-8	-	-	Refractory anemia with excess blasts-1
-8	-	-	Refractory anemia with excess blasts-2
-8	-	-	Refractory anemia with excess of blasts (FAB)
-8	-	-	Refractory anemia with ringed sideroblasts
-8	-	-	Splenic marginal zone B-cell lymphoma
-8	-	-	T-cell granular lymphocytic leukemia
-8	-	-	T-prolymphocytic leukemia
-8	-	-	Waldenstr&ouml;m macroglobulinemia
-9	-	-	Acute erythroleukemia (FAB type M6)
-9	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-9	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-9	-	-	Acute monoblastic leukemia (FAB type M5)
-9	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-9	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-9	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-9	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-9	-	-	Acute myeloid leukemia, NOS
-9	-	-	Acute myeloid leukemia, special type
-9	-	-	Acute myelomonocytic leukemia (FAB type M4)
-9	-	-	Acute promyelocytic leukemia (FAB type M3)
-9	-	-	Acute undifferentiated leukemia
-9	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-9	-	-	Anaplastic large cell lymphoma, systemic type
-9	-	-	Angioimmunoblastic T-cell lymphoma
-9	-	-	Bilineage or biphenotypic leukemia
-9	-	-	B-prolymphocytic leukemia
-9	-	-	Burkitt lymphoma/leukemia
-9	-	-	Chronic lymphocytic leukemia
-9	-	-	Chronic myeloid leukemia, aberrant translocation
-9	-	-	Chronic myeloid leukemia, t(9;22)
-9	-	-	Dendritic cell neoplasm
-9	-	-	Diffuse large B-cell lymphoma
-9	-	-	Follicular lymphoma
-9	-	-	Hodgkin disease, lymphocyte depletion
-9	-	-	Hodgkin disease, lymphocyte predominance
-9	-	-	Hodgkin disease, mixed cellularity
-9	-	-	Hodgkin disease, nodular sclerosis
-9	-	-	Hodgkin disease, NOS
-9	-	-	Idiopathic myelofibrosis
-9	-	-	Intravascular large B-cell lymphoma
-9	-	-	Juvenile myelomonocytic leukemia
-9	-	-	Mantle cell lymphoma
-9	-	-	Mastocytosis
-9	-	-	Mature B-cell neoplasm, NOS
-9	-	-	Mature T- and NK-cell neoplasm, NOS
-9	-	-	Mediastinal large B-cell lymphoma
-9	-	-	Multiple myeloma
-9	-	-	Mycosis fungoides/S&eacute;zary syndrome
-9	-	-	Myelodysplastic syndrome, NOS
-9	-	-	Nodal marginal zone B-cell lymphoma
-9	-	-	Peripheral T-cell lymphoma, unspecified
-9	-	-	Plasma cell leukemia
-9	-	-	Polycythemia vera
-9	-	-	Primary effusion lymphoma
-9	-	-	Refractory anemia
-9	-	-	Refractory anemia with excess blasts-1
-9	-	-	Refractory anemia with excess blasts-2
-9	-	-	Refractory anemia with excess of blasts (FAB)
-9	-	-	Refractory anemia with ringed sideroblasts
-9	-	-	Splenic marginal zone B-cell lymphoma
-9	-	-	T-prolymphocytic leukemia
-9	-	-	Waldenstr&ouml;m macroglobulinemia
-10	-	-	Acute erythroleukemia (FAB type M6)
-10	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-10	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-10	-	-	Acute monoblastic leukemia (FAB type M5)
-10	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-10	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-10	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-10	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-10	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-10	-	-	Acute myeloid leukemia, NOS
-10	-	-	Acute myeloid leukemia, special type
-10	-	-	Acute myelomonocytic leukemia (FAB type M4)
-10	-	-	Acute promyelocytic leukemia (FAB type M3)
-10	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-10	-	-	Aggressive NK-cell leukemia
-10	-	-	Anaplastic large cell lymphoma, systemic type
-10	-	-	Angioimmunoblastic T-cell lymphoma
-10	-	-	Bilineage or biphenotypic leukemia
-10	-	-	B-prolymphocytic leukemia
-10	-	-	Burkitt lymphoma/leukemia
-10	-	-	Chronic eosinophilic leukemia/hypereosinophilic syndrome
-10	-	-	Chronic lymphocytic leukemia
-10	-	-	Chronic myeloid leukemia, aberrant translocation
-10	-	-	Chronic myeloid leukemia, t(9;22)
-10	-	-	Chronic myelomonocytic leukemia
-10	-	-	Chronic myeloproliferative disorder, NOS
-10	-	-	Dendritic cell neoplasm
-10	-	-	Diffuse large B-cell lymphoma
-10	-	-	Essential thrombocythemia
-10	-	-	Extranodal NK/T-cell lymphoma
-10	-	-	Follicular lymphoma
-10	-	-	Hairy cell leukemia
-10	-	-	Hodgkin disease, lymphocyte depletion
-10	-	-	Hodgkin disease, lymphocyte predominance
-10	-	-	Hodgkin disease, mixed cellularity
-10	-	-	Hodgkin disease, nodular sclerosis
-10	-	-	Hodgkin disease, NOS
-10	-	-	Idiopathic myelofibrosis
-10	-	-	Intravascular large B-cell lymphoma
-10	-	-	Lymphoplasmacytic lymphoma
-10	-	-	Mantle cell lymphoma
-10	-	-	Mature B-cell neoplasm, NOS
-10	-	-	Mature T- and NK-cell neoplasm, NOS
-10	-	-	Multiple myeloma
-10	-	-	Mycosis fungoides/S&eacute;zary syndrome
-10	-	-	Myelodysplastic syndrome, NOS
-10	-	-	Nonneoplastic hematologic disorder/lesion
-10	-	-	Peripheral T-cell lymphoma, unspecified
-10	-	-	Plasma cell leukemia
-10	-	-	Polycythemia vera
-10	-	-	Primary effusion lymphoma
-10	-	-	Refractory anemia
-10	-	-	Refractory anemia with excess blasts-1
-10	-	-	Refractory anemia with excess blasts-2
-10	-	-	Refractory anemia with excess of blasts (FAB)
-10	-	-	Refractory anemia with ringed sideroblasts
-10	-	-	Splenic marginal zone B-cell lymphoma
-10	-	-	T-cell granular lymphocytic leukemia
-10	-	-	T-prolymphocytic leukemia
-10	-	-	Waldenstr&ouml;m macroglobulinemia
-11	-	-	Acute erythroleukemia (FAB type M6)
-11	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-11	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-11	-	-	Acute monoblastic leukemia (FAB type M5)
-11	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-11	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-11	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-11	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-11	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-11	-	-	Acute myeloid leukemia, NOS
-11	-	-	Acute myeloid leukemia, special type
-11	-	-	Acute myelomonocytic leukemia (FAB type M4)
-11	-	-	Acute promyelocytic leukemia (FAB type M3)
-11	-	-	Acute undifferentiated leukemia
-11	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-11	-	-	Anaplastic large cell lymphoma, systemic type
-11	-	-	Angioimmunoblastic T-cell lymphoma
-11	-	-	Bilineage or biphenotypic leukemia
-11	-	-	B-prolymphocytic leukemia
-11	-	-	Burkitt lymphoma/leukemia
-11	-	-	Chronic lymphocytic leukemia
-11	-	-	Chronic myeloid leukemia, t(9;22)
-11	-	-	Diffuse large B-cell lymphoma
-11	-	-	Follicular lymphoma
-11	-	-	Hodgkin disease, mixed cellularity
-11	-	-	Hodgkin disease, nodular sclerosis
-11	-	-	Hodgkin disease, NOS
-11	-	-	Idiopathic myelofibrosis
-11	-	-	Mantle cell lymphoma
-11	-	-	Mature B-cell neoplasm, NOS
-11	-	-	Mature T- and NK-cell neoplasm, NOS
-11	-	-	Mediastinal large B-cell lymphoma
-11	-	-	Multiple myeloma
-11	-	-	Mycosis fungoides/S&eacute;zary syndrome
-11	-	-	Myelodysplastic syndrome, NOS
-11	-	-	Peripheral T-cell lymphoma, unspecified
-11	-	-	Plasma cell leukemia
-11	-	-	Refractory anemia
-11	-	-	Refractory anemia with excess blasts-1
-11	-	-	Refractory anemia with excess blasts-2
-11	-	-	Refractory anemia with excess of blasts (FAB)
-11	-	-	Splenic marginal zone B-cell lymphoma
-11	-	-	T-prolymphocytic leukemia
-11	-	-	Waldenstr&ouml;m macroglobulinemia
-12	-	-	Acute erythroleukemia (FAB type M6)
-12	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-12	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-12	-	-	Acute monoblastic leukemia (FAB type M5)
-12	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-12	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-12	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-12	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-12	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-12	-	-	Acute myeloid leukemia, NOS
-12	-	-	Acute myeloid leukemia, special type
-12	-	-	Acute myelomonocytic leukemia (FAB type M4)
-12	-	-	Acute promyelocytic leukemia (FAB type M3)
-12	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-12	-	-	Angioimmunoblastic T-cell lymphoma
-12	-	-	Bilineage or biphenotypic leukemia
-12	-	-	B-prolymphocytic leukemia
-12	-	-	Burkitt lymphoma/leukemia
-12	-	-	Chronic lymphocytic leukemia
-12	-	-	Chronic myeloid leukemia, aberrant translocation
-12	-	-	Chronic myeloid leukemia, t(9;22)
-12	-	-	Chronic myelomonocytic leukemia
-12	-	-	Chronic myeloproliferative disorder, NOS
-12	-	-	Dendritic cell neoplasm
-12	-	-	Diffuse large B-cell lymphoma
-12	-	-	Essential thrombocythemia
-12	-	-	Follicular lymphoma
-12	-	-	Hairy cell leukemia
-12	-	-	Hodgkin disease, mixed cellularity
-12	-	-	Hodgkin disease, nodular sclerosis
-12	-	-	Idiopathic myelofibrosis
-12	-	-	Mantle cell lymphoma
-12	-	-	Mature B-cell neoplasm, NOS
-12	-	-	Mature T- and NK-cell neoplasm, NOS
-12	-	-	Multiple myeloma
-12	-	-	Mycosis fungoides/S&eacute;zary syndrome
-12	-	-	Myelodysplastic syndrome, NOS
-12	-	-	Peripheral T-cell lymphoma, unspecified
-12	-	-	Plasma cell leukemia
-12	-	-	Polycythemia vera
-12	-	-	Primary effusion lymphoma
-12	-	-	Refractory anemia
-12	-	-	Refractory anemia with excess blasts-1
-12	-	-	Refractory anemia with excess blasts-2
-12	-	-	Refractory anemia with excess of blasts (FAB)
-12	-	-	Refractory anemia with ringed sideroblasts
-12	-	-	Refractory cytopenia with multilineage dysplasia
-12	-	-	Splenic marginal zone B-cell lymphoma
-12	-	-	T-cell granular lymphocytic leukemia
-12	-	-	T-prolymphocytic leukemia
-12	-	-	Waldenstr&ouml;m macroglobulinemia
-13	-	-	Acute basophilic leukemia
-13	-	-	Acute erythroleukemia (FAB type M6)
-13	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-13	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-13	-	-	Acute monoblastic leukemia (FAB type M5)
-13	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-13	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-13	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-13	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-13	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-13	-	-	Acute myeloid leukemia, NOS
-13	-	-	Acute myelomonocytic leukemia (FAB type M4)
-13	-	-	Acute promyelocytic leukemia (FAB type M3)
-13	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-13	-	-	Aggressive NK-cell leukemia
-13	-	-	Anaplastic large cell lymphoma, systemic type
-13	-	-	Bilineage or biphenotypic leukemia
-13	-	-	B-prolymphocytic leukemia
-13	-	-	Burkitt lymphoma/leukemia
-13	-	-	Chronic eosinophilic leukemia/hypereosinophilic syndrome
-13	-	-	Chronic lymphocytic leukemia
-13	-	-	Chronic myeloid leukemia, t(9;22)
-13	-	-	Chronic myelomonocytic leukemia
-13	-	-	Dendritic cell neoplasm
-13	-	-	Diffuse large B-cell lymphoma
-13	-	-	Extranodal NK/T-cell lymphoma
-13	-	-	Follicular lymphoma
-13	-	-	Hairy cell leukemia
-13	-	-	Hodgkin disease, lymphocyte depletion
-13	-	-	Hodgkin disease, lymphocyte predominance
-13	-	-	Hodgkin disease, mixed cellularity
-13	-	-	Hodgkin disease, nodular sclerosis
-13	-	-	Hodgkin disease, NOS
-13	-	-	Idiopathic myelofibrosis
-13	-	-	Mantle cell lymphoma
-13	-	-	Mature B-cell neoplasm, NOS
-13	-	-	Mature T- and NK-cell neoplasm, NOS
-13	-	-	Multiple myeloma
-13	-	-	Mycosis fungoides/S&eacute;zary syndrome
-13	-	-	Myelodysplastic syndrome, NOS
-13	-	-	Nodal marginal zone B-cell lymphoma
-13	-	-	Peripheral T-cell lymphoma, unspecified
-13	-	-	Plasma cell leukemia
-13	-	-	Polycythemia vera
-13	-	-	Primary effusion lymphoma
-13	-	-	Refractory anemia
-13	-	-	Refractory anemia with excess blasts-1
-13	-	-	Refractory anemia with excess blasts-2
-13	-	-	Refractory anemia with excess of blasts (FAB)
-13	-	-	Refractory anemia with ringed sideroblasts
-13	-	-	Refractory cytopenia with multilineage dysplasia
-13	-	-	Splenic marginal zone B-cell lymphoma
-13	-	-	T-cell granular lymphocytic leukemia
-13	-	-	T-prolymphocytic leukemia
-13	-	-	Waldenstr&ouml;m macroglobulinemia
-14	-	-	Acute erythroleukemia (FAB type M6)
-14	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-14	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-14	-	-	Acute monoblastic leukemia (FAB type M5)
-14	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-14	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-14	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-14	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-14	-	-	Acute myeloid leukemia, NOS
-14	-	-	Acute myelomonocytic leukemia (FAB type M4)
-14	-	-	Acute promyelocytic leukemia (FAB type M3)
-14	-	-	Acute undifferentiated leukemia
-14	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-14	-	-	Aggressive NK-cell leukemia
-14	-	-	Anaplastic large cell lymphoma, systemic type
-14	-	-	Bilineage or biphenotypic leukemia
-14	-	-	B-prolymphocytic leukemia
-14	-	-	Burkitt lymphoma/leukemia
-14	-	-	Chronic lymphocytic leukemia
-14	-	-	Chronic myeloid leukemia, aberrant translocation
-14	-	-	Chronic myeloid leukemia, t(9;22)
-14	-	-	Dendritic cell neoplasm
-14	-	-	Diffuse large B-cell lymphoma
-14	-	-	Essential thrombocythemia
-14	-	-	Follicular lymphoma
-14	-	-	Hodgkin disease, lymphocyte depletion
-14	-	-	Hodgkin disease, lymphocyte predominance
-14	-	-	Hodgkin disease, mixed cellularity
-14	-	-	Hodgkin disease, nodular sclerosis
-14	-	-	Hodgkin disease, NOS
-14	-	-	Idiopathic myelofibrosis
-14	-	-	Mantle cell lymphoma
-14	-	-	Mature B-cell neoplasm, NOS
-14	-	-	Mature T- and NK-cell neoplasm, NOS
-14	-	-	Multiple myeloma
-14	-	-	Mycosis fungoides/S&eacute;zary syndrome
-14	-	-	Myelodysplastic syndrome, NOS
-14	-	-	Peripheral T-cell lymphoma, unspecified
-14	-	-	Plasma cell leukemia
-14	-	-	Polycythemia vera
-14	-	-	Refractory anemia
-14	-	-	Refractory anemia with excess blasts-1
-14	-	-	Refractory anemia with excess blasts-2
-14	-	-	Refractory anemia with excess of blasts (FAB)
-14	-	-	Refractory anemia with ringed sideroblasts
-14	-	-	Refractory cytopenia with multilineage dysplasia
-14	-	-	Splenic marginal zone B-cell lymphoma
-14	-	-	T-prolymphocytic leukemia
-14	-	-	Waldenstr&ouml;m macroglobulinemia
-15	-	-	Acute erythroleukemia (FAB type M6)
-15	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-15	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-15	-	-	Acute monoblastic leukemia (FAB type M5)
-15	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-15	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-15	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-15	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-15	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-15	-	-	Acute myeloid leukemia, NOS
-15	-	-	Acute myeloid leukemia, special type
-15	-	-	Acute myelomonocytic leukemia (FAB type M4)
-15	-	-	Acute promyelocytic leukemia (FAB type M3)
-15	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-15	-	-	Aggressive NK-cell leukemia
-15	-	-	Anaplastic large cell lymphoma, systemic type
-15	-	-	Angioimmunoblastic T-cell lymphoma
-15	-	-	Bilineage or biphenotypic leukemia
-15	-	-	B-prolymphocytic leukemia
-15	-	-	Burkitt lymphoma/leukemia
-15	-	-	Chronic lymphocytic leukemia
-15	-	-	Chronic myeloid leukemia, aberrant translocation
-15	-	-	Chronic myeloid leukemia, t(9;22)
-15	-	-	Chronic myelomonocytic leukemia
-15	-	-	Dendritic cell neoplasm
-15	-	-	Diffuse large B-cell lymphoma
-15	-	-	Essential thrombocythemia
-15	-	-	Follicular lymphoma
-15	-	-	Hodgkin disease, lymphocyte depletion
-15	-	-	Hodgkin disease, lymphocyte predominance
-15	-	-	Hodgkin disease, mixed cellularity
-15	-	-	Hodgkin disease, nodular sclerosis
-15	-	-	Hodgkin disease, NOS
-15	-	-	Idiopathic myelofibrosis
-15	-	-	Intravascular large B-cell lymphoma
-15	-	-	Lymphoplasmacytic lymphoma
-15	-	-	Mantle cell lymphoma
-15	-	-	Mastocytosis
-15	-	-	Mature B-cell neoplasm, NOS
-15	-	-	Mature T- and NK-cell neoplasm, NOS
-15	-	-	Mediastinal large B-cell lymphoma
-15	-	-	Multiple myeloma
-15	-	-	Mycosis fungoides/S&eacute;zary syndrome
-15	-	-	Myelodysplastic/myeloproliferative disease, NOS
-15	-	-	Myelodysplastic syndrome, NOS
-15	-	-	Nodal marginal zone B-cell lymphoma
-15	-	-	Peripheral T-cell lymphoma, unspecified
-15	-	-	Plasma cell leukemia
-15	-	-	Polycythemia vera
-15	-	-	Post-transplant lymphoproliferative disorder
-15	-	-	Primary effusion lymphoma
-15	-	-	Refractory anemia
-15	-	-	Refractory anemia with excess blasts-1
-15	-	-	Refractory anemia with excess blasts-2
-15	-	-	Refractory anemia with excess of blasts (FAB)
-15	-	-	Refractory anemia with ringed sideroblasts
-15	-	-	Refractory cytopenia with multilineage dysplasia
-15	-	-	Splenic marginal zone B-cell lymphoma
-15	-	-	T-prolymphocytic leukemia
-16	-	-	Acute erythroleukemia (FAB type M6)
-16	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-16	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-16	-	-	Acute monoblastic leukemia (FAB type M5)
-16	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-16	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-16	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-16	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-16	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-16	-	-	Acute myeloid leukemia, NOS
-16	-	-	Acute myeloid leukemia, special type
-16	-	-	Acute myelomonocytic leukemia (FAB type M4)
-16	-	-	Acute promyelocytic leukemia (FAB type M3)
-16	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-16	-	-	Anaplastic large cell lymphoma, systemic type
-16	-	-	Angioimmunoblastic T-cell lymphoma
-16	-	-	Bilineage or biphenotypic leukemia
-16	-	-	Burkitt lymphoma/leukemia
-16	-	-	Chronic lymphocytic leukemia
-16	-	-	Chronic myeloid leukemia, aberrant translocation
-16	-	-	Chronic myeloid leukemia, t(9;22)
-16	-	-	Chronic myelomonocytic leukemia
-16	-	-	Chronic myeloproliferative disorder, NOS
-16	-	-	Diffuse large B-cell lymphoma
-16	-	-	Follicular lymphoma
-16	-	-	Hepatosplenic T-cell lymphoma
-16	-	-	Hodgkin disease, lymphocyte depletion
-16	-	-	Hodgkin disease, mixed cellularity
-16	-	-	Hodgkin disease, nodular sclerosis
-16	-	-	Hodgkin disease, NOS
-16	-	-	Mantle cell lymphoma
-16	-	-	Mature B-cell neoplasm, NOS
-16	-	-	Mature T- and NK-cell neoplasm, NOS
-16	-	-	Multiple myeloma
-16	-	-	Mycosis fungoides/S&eacute;zary syndrome
-16	-	-	Myelodysplastic syndrome, NOS
-16	-	-	Nodal marginal zone B-cell lymphoma
-16	-	-	Peripheral T-cell lymphoma, unspecified
-16	-	-	Plasma cell leukemia
-16	-	-	Polycythemia vera
-16	-	-	Refractory anemia
-16	-	-	Refractory anemia with excess blasts-1
-16	-	-	Refractory anemia with excess blasts-2
-16	-	-	Refractory anemia with excess of blasts (FAB)
-16	-	-	Refractory anemia with ringed sideroblasts
-16	-	-	Refractory cytopenia with multilineage dysplasia
-16	-	-	Splenic marginal zone B-cell lymphoma
-16	-	-	T-prolymphocytic leukemia
-16	-	-	Waldenstr&ouml;m macroglobulinemia
-17	-	-	Acute erythroleukemia (FAB type M6)
-17	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-17	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-17	-	-	Acute monoblastic leukemia (FAB type M5)
-17	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-17	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-17	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-17	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-17	-	-	Acute myeloid leukemia, NOS
-17	-	-	Acute myeloid leukemia, special type
-17	-	-	Acute myelomonocytic leukemia (FAB type M4)
-17	-	-	Acute promyelocytic leukemia (FAB type M3)
-17	-	-	Acute undifferentiated leukemia
-17	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-17	-	-	Anaplastic large cell lymphoma, systemic type
-17	-	-	Angioimmunoblastic T-cell lymphoma
-17	-	-	B-cell lymphoma associated with hemophagocytic syndrome
-17	-	-	Bilineage or biphenotypic leukemia
-17	-	-	B-prolymphocytic leukemia
-17	-	-	Burkitt lymphoma/leukemia
-17	-	-	Chronic lymphocytic leukemia
-17	-	-	Chronic myeloid leukemia, aberrant translocation
-17	-	-	Chronic myeloid leukemia, t(9;22)
-17	-	-	Chronic myelomonocytic leukemia
-17	-	-	Chronic myeloproliferative disorder, NOS
-17	-	-	Dendritic cell neoplasm
-17	-	-	Diffuse large B-cell lymphoma
-17	-	-	Essential thrombocythemia
-17	-	-	Extranodal NK/T-cell lymphoma
-17	-	-	Follicular lymphoma
-17	-	-	Hairy cell leukemia
-17	-	-	Hodgkin disease, lymphocyte depletion
-17	-	-	Hodgkin disease, lymphocyte predominance
-17	-	-	Hodgkin disease, mixed cellularity
-17	-	-	Hodgkin disease, nodular sclerosis
-17	-	-	Hodgkin disease, NOS
-17	-	-	Idiopathic myelofibrosis
-17	-	-	Lymphoplasmacytic lymphoma
-17	-	-	Mantle cell lymphoma
-17	-	-	Mastocytosis
-17	-	-	Mature B-cell neoplasm, NOS
-17	-	-	Mature T- and NK-cell neoplasm, NOS
-17	-	-	Multiple myeloma
-17	-	-	Mycosis fungoides/S&eacute;zary syndrome
-17	-	-	Myelodysplastic syndrome, NOS
-17	-	-	Peripheral T-cell lymphoma, unspecified
-17	-	-	Plasma cell leukemia
-17	-	-	Polycythemia vera
-17	-	-	Refractory anemia
-17	-	-	Refractory anemia with excess blasts-1
-17	-	-	Refractory anemia with excess blasts-2
-17	-	-	Refractory anemia with excess of blasts (FAB)
-17	-	-	Refractory anemia with ringed sideroblasts
-17	-	-	Refractory cytopenia with multilineage dysplasia
-17	-	-	Splenic marginal zone B-cell lymphoma
-17	-	-	T-prolymphocytic leukemia
-17	-	-	Waldenstr&ouml;m macroglobulinemia
-18	-	-	Acute erythroleukemia (FAB type M6)
-18	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-18	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-18	-	-	Acute monoblastic leukemia (FAB type M5)
-18	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-18	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-18	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-18	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-18	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-18	-	-	Acute myeloid leukemia, NOS
-18	-	-	Acute myeloid leukemia, special type
-18	-	-	Acute myelomonocytic leukemia (FAB type M4)
-18	-	-	Acute promyelocytic leukemia (FAB type M3)
-18	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-18	-	-	Aggressive NK-cell leukemia
-18	-	-	Anaplastic large cell lymphoma, cutaneous type
-18	-	-	Anaplastic large cell lymphoma, systemic type
-18	-	-	Angioimmunoblastic T-cell lymphoma
-18	-	-	B-cell lymphoma associated with hemophagocytic syndrome
-18	-	-	Bilineage or biphenotypic leukemia
-18	-	-	B-prolymphocytic leukemia
-18	-	-	Burkitt lymphoma/leukemia
-18	-	-	Chronic lymphocytic leukemia
-18	-	-	Chronic myeloid leukemia, aberrant translocation
-18	-	-	Chronic myeloid leukemia, t(9;22)
-18	-	-	Chronic myelomonocytic leukemia
-18	-	-	Chronic myeloproliferative disorder, NOS
-18	-	-	Dendritic cell neoplasm
-18	-	-	Diffuse large B-cell lymphoma
-18	-	-	Follicular lymphoma
-18	-	-	Hairy cell leukemia
-18	-	-	Hodgkin disease, lymphocyte depletion
-18	-	-	Hodgkin disease, lymphocyte predominance
-18	-	-	Hodgkin disease, mixed cellularity
-18	-	-	Hodgkin disease, nodular sclerosis
-18	-	-	Hodgkin disease, NOS
-18	-	-	Mantle cell lymphoma
-18	-	-	Mature B-cell neoplasm, NOS
-18	-	-	Mature T- and NK-cell neoplasm, NOS
-18	-	-	Multiple myeloma
-18	-	-	Mycosis fungoides/S&eacute;zary syndrome
-18	-	-	Myelodysplastic syndrome, NOS
-18	-	-	Nodal marginal zone B-cell lymphoma
-18	-	-	Nonneoplastic hematologic disorder/lesion
-18	-	-	Peripheral T-cell lymphoma, unspecified
-18	-	-	Plasma cell leukemia
-18	-	-	Polycythemia vera
-18	-	-	Primary effusion lymphoma
-18	-	-	Refractory anemia
-18	-	-	Refractory anemia with excess blasts-1
-18	-	-	Refractory anemia with excess blasts-2
-18	-	-	Refractory anemia with excess of blasts (FAB)
-18	-	-	Refractory anemia with ringed sideroblasts
-18	-	-	Refractory cytopenia with multilineage dysplasia
-18	-	-	Splenic marginal zone B-cell lymphoma
-18	-	-	T-prolymphocytic leukemia
-18	-	-	Waldenstr&ouml;m macroglobulinemia
-19	-	-	Acute erythroleukemia (FAB type M6)
-19	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-19	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-19	-	-	Acute monoblastic leukemia (FAB type M5)
-19	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-19	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-19	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-19	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-19	-	-	Acute myeloid leukemia, NOS
-19	-	-	Acute myeloid leukemia, special type
-19	-	-	Acute myelomonocytic leukemia (FAB type M4)
-19	-	-	Acute promyelocytic leukemia (FAB type M3)
-19	-	-	Acute undifferentiated leukemia
-19	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-19	-	-	Anaplastic large cell lymphoma, systemic type
-19	-	-	Angioimmunoblastic T-cell lymphoma
-19	-	-	B-cell lymphoma associated with hemophagocytic syndrome
-19	-	-	Bilineage or biphenotypic leukemia
-19	-	-	B-prolymphocytic leukemia
-19	-	-	Burkitt lymphoma/leukemia
-19	-	-	Chronic lymphocytic leukemia
-19	-	-	Chronic myeloid leukemia, aberrant translocation
-19	-	-	Chronic myeloid leukemia, t(9;22)
-19	-	-	Chronic myelomonocytic leukemia
-19	-	-	Dendritic cell neoplasm
-19	-	-	Diffuse large B-cell lymphoma
-19	-	-	Follicular lymphoma
-19	-	-	Hairy cell leukemia
-19	-	-	Hodgkin disease, lymphocyte depletion
-19	-	-	Hodgkin disease, lymphocyte predominance
-19	-	-	Hodgkin disease, mixed cellularity
-19	-	-	Hodgkin disease, nodular sclerosis
-19	-	-	Hodgkin disease, NOS
-19	-	-	Idiopathic myelofibrosis
-19	-	-	Intravascular large B-cell lymphoma
-19	-	-	Lymphoplasmacytic lymphoma
-19	-	-	Mantle cell lymphoma
-19	-	-	Mastocytosis
-19	-	-	Mature B-cell neoplasm, NOS
-19	-	-	Mature T- and NK-cell neoplasm, NOS
-19	-	-	Multiple myeloma
-19	-	-	Mycosis fungoides/S&eacute;zary syndrome
-19	-	-	Myelodysplastic syndrome, NOS
-19	-	-	Peripheral T-cell lymphoma, unspecified
-19	-	-	Plasma cell leukemia
-19	-	-	Polycythemia vera
-19	-	-	Refractory anemia
-19	-	-	Refractory anemia with excess blasts-1
-19	-	-	Refractory anemia with excess blasts-2
-19	-	-	Refractory anemia with excess of blasts (FAB)
-19	-	-	Refractory anemia with ringed sideroblasts
-19	-	-	Splenic marginal zone B-cell lymphoma
-19	-	-	T-prolymphocytic leukemia
-19	-	-	Waldenstr&ouml;m macroglobulinemia
-20	-	-	Acute erythroleukemia (FAB type M6)
-20	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-20	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-20	-	-	Acute monoblastic leukemia (FAB type M5)
-20	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-20	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-20	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-20	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-20	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-20	-	-	Acute myeloid leukemia, NOS
-20	-	-	Acute myeloid leukemia, special type
-20	-	-	Acute myelomonocytic leukemia (FAB type M4)
-20	-	-	Acute promyelocytic leukemia (FAB type M3)
-20	-	-	Acute undifferentiated leukemia
-20	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-20	-	-	Aggressive NK-cell leukemia
-20	-	-	Anaplastic large cell lymphoma, cutaneous type
-20	-	-	Anaplastic large cell lymphoma, systemic type
-20	-	-	Angioimmunoblastic T-cell lymphoma
-20	-	-	Bilineage or biphenotypic leukemia
-20	-	-	B-prolymphocytic leukemia
-20	-	-	Burkitt lymphoma/leukemia
-20	-	-	Chronic lymphocytic leukemia
-20	-	-	Chronic myeloid leukemia, aberrant translocation
-20	-	-	Chronic myeloid leukemia, t(9;22)
-20	-	-	Chronic myelomonocytic leukemia
-20	-	-	Diffuse large B-cell lymphoma
-20	-	-	Essential thrombocythemia
-20	-	-	Follicular lymphoma
-20	-	-	Hodgkin disease, lymphocyte depletion
-20	-	-	Hodgkin disease, lymphocyte predominance
-20	-	-	Hodgkin disease, mixed cellularity
-20	-	-	Hodgkin disease, nodular sclerosis
-20	-	-	Hodgkin disease, NOS
-20	-	-	Idiopathic myelofibrosis
-20	-	-	Mantle cell lymphoma
-20	-	-	Mature B-cell neoplasm, NOS
-20	-	-	Mature B-cell neoplasm, special type
-20	-	-	Mature T- and NK-cell neoplasm, NOS
-20	-	-	Multiple myeloma
-20	-	-	Mycosis fungoides/S&eacute;zary syndrome
-20	-	-	Myelodysplastic syndrome, NOS
-20	-	-	Nodal marginal zone B-cell lymphoma
-20	-	-	Peripheral T-cell lymphoma, unspecified
-20	-	-	Plasma cell leukemia
-20	-	-	Polycythemia vera
-20	-	-	Primary effusion lymphoma
-20	-	-	Refractory anemia
-20	-	-	Refractory anemia with excess blasts-1
-20	-	-	Refractory anemia with excess blasts-2
-20	-	-	Refractory anemia with excess of blasts (FAB)
-20	-	-	Refractory anemia with ringed sideroblasts
-20	-	-	Refractory cytopenia with multilineage dysplasia
-20	-	-	Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
-20	-	-	Splenic marginal zone B-cell lymphoma
-20	-	-	T-cell granular lymphocytic leukemia
-20	-	-	T-prolymphocytic leukemia
-20	-	-	Waldenstr&ouml;m macroglobulinemia
-21	-	-	Acute erythroleukemia (FAB type M6)
-21	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-21	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-21	-	-	Acute monoblastic leukemia (FAB type M5)
-21	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-21	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-21	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-21	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-21	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-21	-	-	Acute myeloid leukemia, NOS
-21	-	-	Acute myelomonocytic leukemia (FAB type M4)
-21	-	-	Acute promyelocytic leukemia (FAB type M3)
-21	-	-	Acute undifferentiated leukemia
-21	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-21	-	-	Anaplastic large cell lymphoma, systemic type
-21	-	-	Bilineage or biphenotypic leukemia
-21	-	-	B-prolymphocytic leukemia
-21	-	-	Burkitt lymphoma/leukemia
-21	-	-	Chronic lymphocytic leukemia
-21	-	-	Chronic myeloid leukemia, aberrant translocation
-21	-	-	Chronic myeloid leukemia, t(9;22)
-21	-	-	Chronic myelomonocytic leukemia
-21	-	-	Dendritic cell neoplasm
-21	-	-	Diffuse large B-cell lymphoma
-21	-	-	Essential thrombocythemia
-21	-	-	Follicular lymphoma
-21	-	-	Hodgkin disease, lymphocyte depletion
-21	-	-	Hodgkin disease, lymphocyte predominance
-21	-	-	Hodgkin disease, mixed cellularity
-21	-	-	Hodgkin disease, nodular sclerosis
-21	-	-	Hodgkin disease, NOS
-21	-	-	Intravascular large B-cell lymphoma
-21	-	-	Mantle cell lymphoma
-21	-	-	Mastocytosis
-21	-	-	Mature B-cell neoplasm, NOS
-21	-	-	Mature T- and NK-cell neoplasm, NOS
-21	-	-	Multiple myeloma
-21	-	-	Mycosis fungoides/S&eacute;zary syndrome
-21	-	-	Myelodysplastic/myeloproliferative disease, NOS
-21	-	-	Myelodysplastic syndrome, NOS
-21	-	-	Nodal marginal zone B-cell lymphoma
-21	-	-	Nonneoplastic hematologic disorder/lesion
-21	-	-	Peripheral T-cell lymphoma, unspecified
-21	-	-	Plasma cell leukemia
-21	-	-	Polycythemia vera
-21	-	-	Primary effusion lymphoma
-21	-	-	Refractory anemia
-21	-	-	Refractory anemia with excess blasts-1
-21	-	-	Refractory anemia with excess blasts-2
-21	-	-	Refractory anemia with excess of blasts (FAB)
-21	-	-	Refractory anemia with ringed sideroblasts
-21	-	-	Refractory cytopenia with multilineage dysplasia
-21	-	-	Splenic marginal zone B-cell lymphoma
-21	-	-	T-prolymphocytic leukemia
-21	-	-	Waldenstr&ouml;m macroglobulinemia
-22	-	-	Acute erythroleukemia (FAB type M6)
-22	-	-	Acute lymphoblastic leukemia/lymphoblastic lymphoma
-22	-	-	Acute megakaryoblastic leukemia (FAB type M7)
-22	-	-	Acute monoblastic leukemia (FAB type M5)
-22	-	-	Acute monoblastic leukemia with differentiation (FAB type M5b)
-22	-	-	Acute monoblastic leukemia without differentiation (FAB type M5a)
-22	-	-	Acute myeloblastic leukemia with maturation (FAB type M2)
-22	-	-	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
-22	-	-	Acute myeloblastic leukemia without maturation (FAB type M1)
-22	-	-	Acute myeloid leukemia, NOS
-22	-	-	Acute myelomonocytic leukemia (FAB type M4)
-22	-	-	Acute promyelocytic leukemia (FAB type M3)
-22	-	-	Acute undifferentiated leukemia
-22	-	-	Adult T-cell lymphoma/leukemia (HTLV-1+)
-22	-	-	Aggressive NK-cell leukemia
-22	-	-	Anaplastic large cell lymphoma, systemic type
-22	-	-	Bilineage or biphenotypic leukemia
-22	-	-	B-prolymphocytic leukemia
-22	-	-	Burkitt lymphoma/leukemia
-22	-	-	Chronic lymphocytic leukemia
-22	-	-	Chronic myeloid leukemia, aberrant translocation
-22	-	-	Chronic myeloid leukemia, t(9;22)
-22	-	-	Chronic myelomonocytic leukemia
-22	-	-	Chronic myeloproliferative disorder, NOS
-22	-	-	Dendritic cell neoplasm
-22	-	-	Diffuse large B-cell lymphoma
-22	-	-	Extranodal NK/T-cell lymphoma
-22	-	-	Follicular lymphoma
-22	-	-	Hairy cell leukemia
-22	-	-	Hepatosplenic T-cell lymphoma
-22	-	-	Hodgkin disease, lymphocyte depletion
-22	-	-	Hodgkin disease, mixed cellularity
-22	-	-	Hodgkin disease, nodular sclerosis
-22	-	-	Hodgkin disease, NOS
-22	-	-	Lymphoplasmacytic lymphoma
-22	-	-	Mantle cell lymphoma
-22	-	-	Mastocytosis
-22	-	-	Mature B-cell neoplasm, NOS
-22	-	-	Mature T- and NK-cell neoplasm, NOS
-22	-	-	Multiple myeloma
-22	-	-	Mycosis fungoides/S&eacute;zary syndrome
-22	-	-	Myelodysplastic syndrome, NOS
-22	-	-	Nodal marginal zone B-cell lymphoma
-22	-	-	Peripheral T-cell lymphoma, unspecified
-22	-	-	Plasma cell leukemia
-22	-	-	Post-transplant lymphoproliferative disorder
-22	-	-	Primary effusion lymphoma
-22	-	-	Refractory anemia
-22	-	-	Refractory anemia with excess blasts-1
-22	-	-	Refractory anemia with excess blasts-2
-22	-	-	Refractory anemia with excess of blasts (FAB)
-22	-	-	Refractory anemia with ringed sideroblasts
-22	-	-	Refractory cytopenia with multilineage dysplasia
-22	-	-	Splenic marginal zone B-cell lymphoma
-22	-	-	T-prolymphocytic leukemia
-22	-	-	Waldenstr&ouml;m macroglobulinemia
